ARCHIVES

Waksals Keep ImClone Jobs, BMS Pumps $200M Into C225

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Cancer Program Advocates, Success Overcame Powerful Negative Factors To Win Budget Fight

August 10, 1979

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

Seer Gets Concept Approval For Three More Years, With Several Changes

June 19, 1981

Skin Cancer Screens Find “Extraordinary High” Rates

September 20, 1985

Crout, Finkel Replaced at FDA; Hayes Combine Biologics, Drugs

April 2, 1982

In Brief: Robert Weinberg to Receive Bristol-Myers Award; Leffall Chosen for Poster Series

April 13, 1984